Announcements

The latest Impact Factors have been released and are updated in our site!

Not a Current Subscriber?

Subscribe Now

5642 Journals

4484 Congresses

10100+ Unique Records

eJHaem

Title Abbreviation

EJHaem

Electronic ISSN

2688-6146

Therapeutic Area

Biotechnology, Health Economics/Outcomes Research, Hematology, Immunology, Oncology, Research

Readership

Bioengineers, Biomedical Engineers/Technologists, Biomedical Researchers, Cell Biologists, Clinicians, Epidemiologists, Hematologists, Immunologists, Oncologists, Researchers

Scope

eJHaem is an Open Access (OA) journal owned by Wiley and the British Society for Haematology publishing high-quality original articles covering a broad array of haematology topics. The journal accepts direct submissions as well as content that is cascaded from the top quartile journals British Journal of Haematology and American Journal of Hematology. Haematology topics of interest for the journal include clinical and translational research in the epidemiology, etiology, diagnosis, prognosis, and novel therapeutic advances in plasma cell neoplasms, myeloproliferative neoplasms, lymphoid and myeloid malignancies, and benign haematology. In addition, submission of longer articles and publications with novel formatting will be encouraged as will burgeoning areas of interest such as “real world evidence”, “decision making”, “health economics”, “immune effector cell therapies”, “biomarker discovery”, and other impactful translational topics. Furthermore, eJHaem will publish haematology topics representing including areas of research in under-represented regions of the world and unique translational research fields (e.g., bio-engineering; systems biology; big data; comparative oncology; etc). Articles reporting clinical trials that will ultimately improve the design of targeted therapies and contribute to improved patient treatment are of high interest. Methods papers will also be considered. eJHaem is a Gold OA, sound science, journal. The OA, electronic only format enables the journal to nimbly and quickly publish key advances in the field of haematology. This will include the ability to harness medium of rapid and novel information dissemination such as use of podcasts, video blogs, and other innovative methods of audio and video broadcast. The journal will also cultivate an awareness of new trends to maintain openness to unique scientific concepts that emerge.

Sponsoring Association(s)

British Society for Haematology (BSH)

Publisher Name

John Wiley & Sons, Inc. - NJ

To see more details about eJHaem, Subscribe Now!

Frequency Author Submission Guidelines

Testimonials

"PubsHub [Journals & Congresses] is an indispensable tool when trying to find the perfect home for a manuscript. It is an unbeatable aid when it comes to wise and efficient journal selection."
	– Kait G Editorial-Project Editor
"It’s useful for establishing publication timelines, communicating them to management and setting expectations accordingly"
	– Michael K. Medical Communications Leader
"…a gold mine of information for clinicians and scientists who are trying to determine where to publish their research."
	- Weill Cornell Medical Library

Journals ● Congresses ● Associations

Privacy Policy ● Terms of Service ● Glossary ● OSS ● Contact Us